Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19

The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, u...

Full description

Bibliographic Details
Main Authors:	Peng, Y, Mentzer, A, Liu, G, Yao, X, Yin, Z, Dong, D, Dejnirattisai, W, Rostron, T, Screaton, G, Mongkolsapaya, J, Knight, J, Ogg, G, Dong, T
Format:	Journal article
Language:	English
Published:	Nature 2020

Similar Items

Reduced neutralization of SARS-CoV-2 B.1.617 by vaccine and convalescent serum
by: Liu, C, et al.
Published: (2021)

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera
by: Supasa, P, et al.
Published: (2021)

Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
by: Zhou, D, et al.
Published: (2020)

Evaluation of T cell responses to naturally processed variant SARS-CoV-2 spike antigens in individuals following infection or vaccination.
by: Yin, Z, et al.
Published: (2023)

Convalescent plasma and hyperimmune immunoglobulin to prevent infection with SARS‐CoV‐2
by: Valk, SJ, et al.
Published: (2021)

SARS-CoV-2 mutations affect antigen processing by the proteasome to alter CD8+ T cell responses
by: Wellington, D, et al.
Published: (2023)

Potential CD8+ T cell cross-reactivity against SARS-CoV-2 conferred by other coronavirus strains
by: Lee, CH, et al.
Published: (2020)

Convalescent plasma donors show enhanced cross-reactive neutralizing antibody response to antigenic variants of SARS-CoV-2 following immunization
by: Harvala, H, et al.
Published: (2022)

Effects of SARS-CoV-2 strain variation on virus neutralisation titres: therapeutic use of convalescent plasma
by: Nguyen, D, et al.
Published: (2021)

The impact of viral mutations on recognition by SARS-CoV-2 specific T-cells
by: de Silva, TI, et al.
Published: (2021)

Resistance of SARS-CoV-2 variants to neutralization by convalescent plasma from early COVID-19 outbreak in Singapore
by: Wang, Bei, et al.
Published: (2021)

Human basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoprotein
by: Ragotte, RJ, et al.
Published: (2021)

Human basigin (CD147) does not directly interact with SARS-CoV-2 spike glycoprotein
by: Ragotte, R, et al.
Published: (2021)

HLA-E-restricted SARS-CoV-2-specific T cells from convalescent COVID-19 patients suppress virus replication despite HLA class Ia down-regulation
by: Yang, H, et al.
Published: (2023)

Differential remodeling of a T-cell transcriptome following CD8- versus CD3-induced signaling.
by: Abidi, S, et al.
Published: (2008)

Feasibility of using convalescent plasma immunotherapy for MERS-CoV infection, Saudi Arabia
by: Arabi, Y, et al.
Published: (2016)

CD44 and cancer.
by: Jackson, D, et al.
Published: (1993)

Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
by: Nhu, LNT, et al.
Published: (2024)

Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals.
by: Tomiyama, H, et al.
Published: (2000)

Reduced neutralisation of SARS-CoV-2 omicron B.1.1.529 variant by post-immunisation serum
by: Dejnirattisai, W, et al.
Published: (2021)

The antigenic anatomy of SARS-CoV-2 receptor binding domain
by: Dejnirattisai, W, et al.
Published: (2021)

Antibody evasion by the P.1 strain of SARS-CoV-2
by: Dejnirattisai, W, et al.
Published: (2021)

Neuropsychiatric disorders following SARS-CoV-2 infection
by: Harrison, PJ, et al.
Published: (2023)

Structural basis of broad SARS-CoV-2 cross-neutralization by affinity-matured public antibodies
by: Sheward, DJ, et al.
Published: (2024)

CD4(-)CD8alphaalpha subset of CD1d-restricted NKT cells controls T cell expansion.
by: Ho, L, et al.
Published: (2004)

Chronic immune activation and CD4+ Tcell lymphopenia in healthy African individuals: Perspectives for SARS-CoV-2 vaccine efficacy
by: Wolday, D, et al.
Published: (2021)

Identify human cluster of differentiation 147 (CD147), a new target of SARS-CoV-2 invasion
by: Al-Salih, Moatasem, et al.
Published: (2020)

The antibody response to SARS-CoV-2 Beta underscores the antigenic distance to other variants
by: Liu, C, et al.
Published: (2021)

T-cell immunotherapy of allergic disease: the role of CD8+ T cells.
by: Ogg, G
Published: (2003)

Inhibition of innate immune responses to tumours by CD4+CD25+ regulatory T cells
by: Richards, H, et al.
Published: (2005)

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2
by: Townsend, A, et al.
Published: (2021)

Deep learning guided optimization of human antibody against SARS-CoV-2 variants with broad neutralization
by: Shan, Sisi, et al.
Published: (2022)

The ChAdOx1 vectored vaccine, AZD2816, induces strong immunogenicity against SARS-CoV-2 beta (B.1.351) and other variants of concern in preclinical studies
by: Spencer, AJ, et al.
Published: (2022)

THE GENOMIC ORGANIZATION OF THE HUMAN CD44 GENE
by: Bell, M, et al.
Published: (1993)

Quantitation of antigen-specific CD8+ T-cell responses.
by: Ogg, G, et al.
Published: (1999)

Neutralizing antibodies in convalescent patients
by: Uhl, LFK, et al.
Published: (2020)

Comprehensive screening reveals strong and broadly directed human immunodeficiency virus type 1-specific CD8 responses in perinatally infected children.
by: Feeney, M, et al.
Published: (2003)

Differentiation and activation antigens on CD8 T cells
by: Mongkolsapaya, J, et al.
Published: (1996)

Der p 1-specific CD4+ T cells in individuals with atopic dermatitis
by: Ardern-Jones, MR, et al.
Published: (2008)

Sensitivity and specificity of two WHO approved SARS-CoV2 antigen assays in detecting patients with SARS-CoV2 infection
by: Jeewandara, C, et al.
Published: (2022)